Abstract

A few broadly neutralizing antibodies, isolated from HIV-1 infected individuals, recognize epitopes in the membrane proximal external region (MPER) of gp41 that are transiently exposed during viral entry. The best characterized, 4E10 and 2F5, are polyreactive, binding to the viral membrane and their epitopes in the MPER. We present a model to calculate, for any antibody concentration, the probability that during the pre-hairpin intermediate, the transient period when the epitopes are first exposed, a bound antibody will disable a trivalent gp41 before fusion is complete. When 4E10 or 2F5 bind to the MPER, a conformational change is induced that results in a stably bound complex. The model predicts that for these antibodies to be effective at neutralization, the time to disable an epitope must be shorter than the time the antibody remains bound in this conformation, about five minutes or less for 4E10 and 2F5. We investigate the role of avidity in neutralization and show that 2F5 IgG, but not 4E10, is much more effective at neutralization than its Fab fragment. We attribute this to 2F5 interacting more stably than 4E10 with the viral membrane. We use the model to elucidate the parameters that determine the ability of these antibodies to disable epitopes and propose an extension of the model to analyze neutralization data. The extended model predicts the dependencies of for neutralization on the rate constants that characterize antibody binding, the rate of fusion of gp41, and the number of gp41 bridging the virus and target cell at the start of the pre-hairpin intermediate. Analysis of neutralization experiments indicate that only a small number of gp41 bridges must be disabled to prevent fusion. However, the model cannot determine the exact number from neutralization experiments alone.

Highlights

  • A small but growing number of HIV-1 broadly neutralizing monoclonal antibodies have been isolated from HIV-1 infected individuals

  • We present a model to calculate the probability pb of an epitope that is only present in the pre-hairpin intermediate being disabled by a monoclonal antibodies (mAbs) or Fab at a solution concentration A

  • The model starts at time t~0 when binding between a target cell and an HIV has occurred and the epitope in the membrane proximal external region (MPER) first becomes accessible on the viral surface

Read more

Summary

Introduction

A small but growing number of HIV-1 broadly neutralizing monoclonal antibodies (mAbs) have been isolated from HIV-1 infected individuals (reviewed in [1]). Each has been shown to be polyreactive [4,5,6], with an elongated heavy chain complementarity determining region 3 (CDRH3) that has a hydrophobic surface that does not contact the peptide antigen [7,8], but that contributes to the ability of 4E10 and 2F5 to bind to the virion membrane and to broadly neutralise [9,10,11,12,13]. Of the two mAbs, 2F5 interacts more strongly with membrane as demonstrated by its ability to bind to virus-like particles bearing no envelop glycoprotein (Env spikes) [6]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.